Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: The tear cationic protein lactoferrin increases the activity of various antimicrobial agents against suspended bacterial cultures including Staphylococcus epidermidis, the predominant causative agent of intraocular lens biofilm infections. We investigated the ability of lactoferrin to enhance the activity of vancomycin and lysozyme against biofilms of a clinical S. epidermidis isolate. METHODS: Biofilms were prepared on soft contact lenses and cells released from the biofilm surface were collected from the surrounding broth. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against the intact biofilm, released cells and suspended bacteria were evaluated using vancomycin with and without lactoferrin. RESULTS: Lactoferrin induced a two-fold reduction in the MBC of vancomycin for biofilm (p < 0.01) and biofilm-released cells from 64 microg/ml to 32 microg/ml and similarly decreased the MIC for biofilm-released cells (p < 0.01) from 32 microg/ml to 16 microg/ml. With or without lactoferrin, the MIC of vancomycin for suspended cells (2 and 4 microg/ml respectively) was less (p < 0.01) than that of both the biofilm (32 and 32 microg/ml) and biofilm-released cells (16 and 32 microg/ml). Lactoferrin did not reduce the MIC of lysozyme, but, at a lysozyme concentration of 16 mg/ml, did significantly (p < 0.05) reduce the number of viable biofilm and biofilm-released cells. CONCLUSIONS: Lactoferrin displays potential as an adjunctive agent to vancomycin in the treatment of S. epidermidis biofilm infections, such as endophthalmitis, associated with intraocular lenses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elucidation of the antistaphylococcal action of lactoferrin and lysozyme
Leitch, E. C., & Willcox, M. D. P. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-9-867 · Cited by 128
Self-citation
Cited by
Ballard, O., & Morrow, A. L. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.10.002 · Cited by 2,598
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Neuhaus, F. C., & Baddiley, J. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.686-723.2003 · Cited by 1,031
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026
“Lactoferrin can also be bactericidal by binding lipopolysaccharide and disrupting bacterial membranes, and it can enhance killing by other antibiotic”
BackgroundAntimicrobial properties of lactoferrin
JENSSEN, H., & HANCOCK, R. (2009) · Biochimie · doi:10.1016/j.biochi.2008.05.015 · Cited by 509
Lactoferrin a multiple bioactive protein: an overview
García-Montoya, I. A., Cendón, T. S., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.018 · Cited by 473
Antimicrobial compounds in tears
McDermott, A. M. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.07.014 · Cited by 290
Role of lactoferrin in the tear film
FLANAGAN, J., & WILLCOX, M. (2009) · Biochimie · doi:10.1016/j.biochi.2008.07.007 · Cited by 221
“epidermidis biofilms to the antimicrobial action of vancomycin [64].”
BackgroundSelf-citationRogan, M. P., Taggart, C. C., Greene, C. M., Murphy, P. G., O’Neill, S. J., & McElvaney, N. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/423821 · Cited by 171
Elucidation of the antistaphylococcal action of lactoferrin and lysozyme
Leitch, E. C., & Willcox, M. D. P. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-9-867 · Cited by 128
Self-citation
Metadata
- Authors
- Leitch, E. C., & Willcox, M. D. P.
- Venue
- Current Eye Research
- Publisher
- Informa UK Limited
- Published
- 1999-01
- Volume
- 19
- Issue
- 1
- Pages
- 12-19
- ISSN
- 0271-3683 (ISSN-L)
- 1460-2202
- OpenAlex
- W2143426164
- Cited by
- 89
- References
- 1
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.